Early research (Phase 1)Study completedNCT01316055
What this trial is testing
Pharmacokinetics (PK) of Dalfampridine-ER 7.5 mg BID in Healthy Volunteers and Subjects With Mild or Moderate Renal Impairment
Who this might be right for
Renal Insufficiency
Acorda Therapeutics 42